Theranos Founder Holmes Receives 90-Year Federal Health Program Ban
Elizabeth Holmes, the founder of Theranos, has been banned from federal health programs for 90 years [...]
Lutathera’s Promise: A Potential $1 Billion First-Line Treatment Market
Novartis's drug Lutathera showed promise in a phase 3 trial for treating certain advanced gastroenteropancreatic neuroendocrine [...]
2024-2025 Top 10 HEOR Trends: ISPOR Report on Key Healthcare Decision-Making Factors
ISPOR, the Professional Society for Health Economics and Outcomes Research, published its “2024-2025 Top 10 HEOR [...]
Rising Prescription Drug Prices in 2020: AARP Report Highlights Excessive Cost Increases
In 2020, AARP identified the top 10 drugs with price increases exceeding the 1.3% inflation rate. [...]
Revolutionizing IVF: UC San Diego Researchers Develop Non-Invasive Embryo Quality Prediction Method
Researchers at UC San Diego School of Medicine have developed a new method to improve the [...]
Biotech Industry Updates: Major Ventures, Partnerships, and Corporate Changes
Jennifer Doudna's Latest Venture: Doudna's lab published a study in Nature Biotechnology about using antibody fragments [...]
Challenges in Removing B/Yamagata Component from Global Flu Vaccines Amid Regulatory Complexities
In response to the disappearance of the B/Yamagata strain of flu B virus during the COVID-19 [...]
Biotech Industry Navigates Bear Market: Shifting Investment Trends and Emerging Opportunities
The biotech industry is grappling with a bear market, leading investors to adopt more cautious strategies. [...]
Global Healthcare Convergence: Booming Market Driven by Technological Integration and Remote Patient Monitoring (2024-2031)
The healthcare convergence market, blending medical devices, digital health, telehealth, and remote patient monitoring, aims to [...]
Canon Medical and Olympus Partner to Enhance Endoscopic Ultrasonography and Expand Global Reach
Canon Medical Systems and Olympus have partnered to enhance the image quality of Endoscopic Ultrasonography (EUS) [...]
Telemedicine Trends and Challenges: Insights from IQVIA’s 2023 Remote Patient Care Study
The first article of a three-part series examines telemedicine’s role in healthcare, based on IQVIA’s “Remote [...]
Kyverna Therapeutics Eyes IPO Amid Rising Interest in CAR-T Therapy for Autoimmune Diseases
According to Endpoints News, Kyverna Therapeutics, a clinical-stage biotech specializing in CAR-T cell therapy for autoimmune [...]
Takeda Acquires Nimbus’ TYK2 Inhibitor TAK-279 in a $4 Billion Deal, Intensifying Competition in Immunology
In late 2022, Takeda moved significantly in the immunology sector by acquiring Nimbus Therapeutics’ tyrosine kinase [...]
Revolutionizing Cancer Care: Integration of Genomic and Clinical Data in Precision Oncology
This study, published in Nature Medicine and led by institutions like Genomics England, NHS England, and [...]
Global Study Reveals High Use of Unregulated Weight-Loss Products Among Teens: Urgent Need for Action
Nearly 1 in 10 teenagers around the world are resorting to risky, unregulated weight-loss products like [...]
Debating the Value and Cost of AI Mammogram Analysis in Breast Cancer Detection
Radiology clinics offer artificial intelligence (AI) analysis of mammograms for $40, but insurance doesn't cover it. [...]
Sanofi CEO Paul Hudson Outlines Bold M&A and R&D Strategy for a Transformative Year Ahead
At the JP Morgan Healthcare Conference, Sanofi CEO Paul Hudson outlined the company's forward-looking strategy, emphasizing [...]
Dexcom’s Record-Breaking 2023: Major Launches, Expanded Coverage, and Exceptional Financial Growth
In 2023, a continuous glucose monitor manufacturer, Dexcom, reported a significant year marked by a major [...]
Boston Scientific to Acquire Axonics for $3.7 Billion, Expanding Urology Portfolio with Neurostimulation Therapies
Boston Scientific has announced a $3.7 billion acquisition of Axonics, a key player in neurostimulation therapies [...]
Merck Acquires Harpoon Therapeutics for $680 Million to Bolster Oncology Pipeline
Merck has agreed to acquire Harpoon Therapeutics for $680 million, significantly enhancing its cancer treatment portfolio [...]
Metagenomi Announces IPO Amid Biotech Sector’s Cooling Investor Interest
Metagenomi, a preclinical gene editing biotech, announced its initial public offering (IPO) plans, aiming to list [...]
FDA Approves Florida’s Plan to Import Prescription Drugs from Canada
The Biden administration has approved Florida Governor Ron DeSantis' plan to import certain prescription drugs from [...]
Walgreens Adopts New Drug Pricing Models and Cost-Cutting Measures under CEO Tim Wentworth’s Leadership
Walgreens Boots Alliance, under the new leadership of CEO Tim Wentworth, is preparing to adopt new [...]
Recent Developments in Healthcare and Pharmaceutical Industry: CVS Health’s Decision, Insulin Price Cap, Alzheimer’s Research, FDA Investigations, and AI Prescription Assistant Launch
CVS Health Removing Humira from Some Drug Lists: CVS Health plans to drop AbbVie’s rheumatoid arthritis [...]
Global Specialty Pharmaceutical Market Forecast: Rapid Growth to USD 1.5 Trillion by 2033
The Global Specialty Pharmaceutical Market is projected to grow from USD 68.3 billion in 2023 to [...]